References

  1. Tidwell JL, Seaman SA, Vanderploeg EJ, Tom S. In vitro and in vivo characterization of OSTEOAMP allogeneic morphogenetic proteins. Data on file, Bioventus white paper; 2017.
  2. Roh JS, Yeung CA, Field JS, McClellan RT. Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: a radiographic and economic analysis. J Orthop Surg Res. 2013;8:49. doi:10.1186/1749-799X-8-49.
  3. Field J, Yeung C, Roh J. Clinical evaluation of allogeneic growth factor in cervical spine fusion. J Spine. 2014;3(158) doi:10.4172/2165-7939.1000158.
  4. Data on File.
  5. Scarpone MA, Kuebler D, Harrell DB. Marrow Cellution Bone Marrow Aspiration System and Related Concentrations of Stem and Progenitor Cells. (White Paper). Avon, MA: Ranfac Corporation Website. http://static1.squarespace.com/static/558b06c6e4b0396e7a146066/t/562556ece4b09867effe2d51/1445287660937/Marrow+Cellution+Scarpone+White+Paper.pdf. Accessed January 5, 2016.
  6. Yang SS. Compositions and Methods to Repair Osseous Defects. US Patent 6,228,386 (2001).
  7. Hench LL. The story of Bioglass. J Mater Sci Mater Med. 2006;17(11):967-78.
  8. Gerhardt LC, Boccaccini AR. Bioactive glass and glass-ceramic scaffolds for one tissue engineering. Materials. 2010;3(7):3867-910.
  9. Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res. 2001;55(2):151-7.
  10. Daculsi G, Layrolle P. Osteoinductive properties of micro macroporous biphasic calcium phosphate bioceramics. Key Eng. Mater. 2004;254-256:1005-1008.
  11. Daculsi G. Jegoux, Layrolle P. The micro macroporous biphasic calcium phosphate concept for bone regeneration and tissue engineering. Advanced Biomaterials: Fundamentals, Processing & Applications. 2009;Section 1,Chapter 4:101-142.
  12. Data on file. RPT-000541 BioStructures Technical Whitepapers.
  13. Garrido CA, Lobo SE, Turíbio FM, Legeros RZ. Biphasic calcium phosphate bioceramics for orthopaedic reconstructions: clinical outcomes. Int J Biomater. 2011;2011:129727.
  14. Cavagna R, Daculsi G, Bouler JM. Macroporous Calcium Phosphate Ceramic: A Prospective Study of 106 Cases in Lumbar Spinal Fusion. J Long-Term Effects Med Implants, 1999;9:403-12.
  15. Betz RR. Limitations of Autograft and Allograft: New Synthetic Solutions. Orthopedics 2002;25(5):561-70.
  16. Pettine KA, Murphy MB, Suzuki RK, Sand TT. Percutaneous injection of autologous bone marrow concentrate cells significantly reduces lumbar discogenic pain through 12 months. Stem Cells 2015;333(1)46-56.
  17. Hegde V, Shonuga O, Ellis S, et al. A prospective comparison of 3 approved systems for autologous bone marrow concentration demonstrated nonequivalency in progenitor cell number and concentration. J Orthop Trauma 2014;28(10):591-8.
  18. Data on file. RPT-000828 – OSTEOMATRIX+ Fluid Uptake Assessment.
  19. Daculsi G, Laboux O, Malard O, Weiss P. Current state of the art of biphasic calcium phosphate bioceramics. J Mater Sci Mater Med 2003;14(3):195-200.
  20. LeGeros RZ, Lin S, Rohanizadeh R, Mijares D, LeGeros JP. Biphasic calcium phosphate bioceramics: preparation, properties and applications. J Mater Sci Mater Med. 2003;14(3):201-9.
  21. Fellah BH, Gauthier O, Weiss P, Chappard D, Layrolle P. Osteogenicity of biphasic calcium phosphate ceramics and bone autograft in a goat model. Biomaterials.2008;29(9):1177-88.
  22. Data on file. RPT-000541 BioStructures Technical Whitepapers.
  23. Data on file RPT-000858. OSTEOAMP Absorption Data.
  24. Roberts T T, Rosenbaum A J. Bone grafts, bone substitutes and orthobiologics; the bridge between basic science and clinical advancements in fracture healing. Organogenesis. 2012;8(4):114-24. doi: 10.4161/org.23306.
  25. Hankenson KD, Dishowitz M, Gray C, Schenker M. Angiogenesis in bone regeneration. Injury. 2011;42(6):556-61. doi: 10.1016/j.injury.2011.03.035.